SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 2,335.89 |
| Enterprise Value ($M) | 2,301.08 |
| Book Value ($M) | 429.17 |
| Book Value / Share | 6.66 |
| Price / Book | 5.44 |
| NCAV ($M) | 395.24 |
| NCAV / Share | 6.00 |
| Price / NCAV | 5.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.33 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.47 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.87 |
| Current Ratio | 13.87 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 431.69 |
| Assets | 465.63 |
| Liabilities | 36.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 6.88 |
| Operating Income | -142.04 |
| Net Income | -141.43 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -107.29 |
| Cash from Investing | -105.78 |
| Cash from Financing | 218.46 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Eventide Asset Management, Llc | 6.64 | ||
| 13G | Kynam Capital Management, LP | 5.50 | ||
| 13G/A | Point72 Asset Management, L.P. | 5.00 | -23.91 | |
| 13G/A | Rtw Investments, Lp | 6.30 | 12.29 | |
| 13G/A | Vanguard Group Inc | 5.57 | 21.20 | |
| 13G | Polar Capital Holdings Plc | 5.73 | ||
| 13G/A | Fmr Llc | 12.89 | -0.21 | |
| 13G/A | Wellington Management Group Llp | 11.84 | 35.45 | |
| 13G/A | BlackRock Inc. | 6.70 | 13.98 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 32,659 | 171,875 | 19.00 | |
| 98,130 | 354,766 | 27.66 | |
| 35,226 | 168,980 | 20.85 | |
| 49,808 | 182,190 | 27.34 | |
| 77,725 | 159,449 | 48.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CGEN – Compugen Ltd. | CING – Cingulate Inc. |
| CKPT – Checkpoint Therapeutics, Inc. | CLNN – Clene Inc. |
| CLRB – Cellectar Biosciences, Inc. |